Skip to main content


4/13/2021 - Cumberland County Statement Regarding the J & J Vaccinations
The New Jersey Department of Health (NJDOH) has notified the Administration of Cumberland County and the Cumberland County Department of Health (CCDOH) that the NJDOH will be following the guidance of the U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) by pausing immediately the administration of the Johnson and Johnson vaccine across all sites in New Jersey.

The NJDOH advises that the CDC and the FDA are reviewing the data involving six reported cases—among nearly 7 million doses administered in the U.S.—in women between the ages of 18 and 48 who received the J&J vaccine. Symptoms occurred 6 to 13 days after vaccination. In these cases, a type of blood clot called cerebral venous sinus thrombosis was seen in combination with low levels of blood platelets. Both the CDC and FDA have said that these adverse events are extremely rare. According to the FDA and CDC, individuals who have received the vaccine and develop abdominal pain, leg pain, shortness of breath, severe headache or other unusual symptoms within three weeks after vaccination should contact their health care provider.

The NJDOH has ordered all New Jersey vaccination sites to cancel or put on hold appointments for the J&J vaccine until further notice. For individuals scheduled to receive the J&J vaccine, the NJ Department of Health has indicated that they will work with the Cumberland County Department of Health and all other vaccination sites to make arrangements for the administration of an alternative two-dose vaccine. The NJDOH also indicates it will also work with the CCDOH and other sites to reschedule appointments.

The NJDOH has advised the CCDOH that it will await further guidance from the federal government before proceeding with additional Johnson and Johnson vaccinations noting that the federal Advisory Committee on Immunization Practices (ACIP) is scheduled to hold an emergency meeting tomorrow to discuss these adverse events and make recommendations to the CDC on how to proceed.


Download Our App.

164 W. Broad St., Bridgeton, NJ 08302
Phone: (856) 453-2125